IDPC has now published three reports and organised a side event at CND and a high-level seminar to promote more efficient strategies to manage illicit drug markets.
In February, IDPC held a meeting in the UK with some of its members to review its mission, vision and strategy for the coming three years, and to empower a group of individuals to speak on behalf of the Consortium at events and conferences.
As a response to rising levels of use, particularly in South East Asia, the CND has passed resolutions urging member states to employ national control systems to restrict the use of ketamine to medical and scientific purposes within their own jurisdictions, but INCB fails to account for the broader health implications of its proposal.
The meeting aimed to mend broken relationships, establish a platform for future engagement, and develop a clear action plan for the coming two years to address the concerns that had been raised.
The revised guidance provides countries with a more user-friendly framework of indicators and targets – including important new measures of the drug policy environment in which they operate.
In December 2012, individuals representing community, civil society, government and intergovernmental bodies met to engage in informal dialogue about drug policy issues in Southeast Asia and India.
In September 2012, I was invited to rapporteur for HIT’s second “Hot Topics” conference in the UK, which attracted 140 delegates from across the country.
